We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

118 hedge funds and large institutions have $990M invested in AnaptysBio in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

19% more capital invested

Capital invested by funds: $831M → $990M (+$159M)

4% more funds holding

Funds holding: 114 → 118 (+4)

6% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $1.13M

0.35% more ownership

Funds ownership: 115.29% → 115.64% (+0.35%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

11% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 38

Holders
118
Holders Change
+4
Holders Change %
+3.51%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
34
Reduced
38
Closed
10
Calls
$1.21M
Puts
$1.13M
Net Calls
+$71K
Net Calls Change
-$6.14M

Top Buyers

Rank Fund Capital Flow
1
5VM
5AM Venture Management
California
+$10.1M
2
BBA
Baker Bros. Advisors
New York
+$9.85M
3
Millennium Management
Millennium Management
New York
+$8.32M
4
LGM
Logos Global Management
California
+$7.06M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.28M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$13.1M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$11.4M
3
DTC
Deep Track Capital
Connecticut
-$9.18M
4
DM
Deerfield Management
New York
-$8.61M
5
State Street
State Street
Massachusetts
-$4.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$6.63M -$301K -10,645 -5%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$5.4M -$65K -2,302 -1%
N
28
Nuveen
North Carolina
$4.95M -$1.92M -68,088 -30%
Charles Schwab
29
Charles Schwab
California
$4.61M +$94.4K +3,343 +2%
Goldman Sachs
30
Goldman Sachs
New York
$3.33M +$324K +11,487 +12%
Morgan Stanley
31
Morgan Stanley
New York
$2.97M -$329K -11,652 -11%
ECM
32
ExodusPoint Capital Management
New York
$2.95M +$1.67M +59,017 +163%
Macquarie Group
33
Macquarie Group
Australia
$2.9M – – –
Two Sigma Advisers
34
Two Sigma Advisers
New York
$2.69M +$861K +30,500 +54%
Bank of America
35
Bank of America
North Carolina
$2.43M -$75.4K -2,671 -3%
Fisher Asset Management
36
Fisher Asset Management
Washington
$2.4M – – –
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.39M -$199K -7,057 -8%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$2.18M -$208K -7,366 -9%
JAM
39
Jupiter Asset Management
United Kingdom
$1.85M – – –
Ameriprise
40
Ameriprise
Minnesota
$1.62M -$25K -885 -2%
UBS Group
41
UBS Group
Switzerland
$1.61M +$1.16M +41,097 +384%
Ensign Peak Advisors
42
Ensign Peak Advisors
Utah
$1.35M -$136K -4,800 -10%
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.27M +$22.6K +800 +2%
Barclays
44
Barclays
United Kingdom
$1.25M -$238K -8,422 -17%
FWM
45
FMB Wealth Management
California
$1.22M +$1.11M +39,259 New
Deutsche Bank
46
Deutsche Bank
Germany
$1.12M +$62.7K +2,221 +7%
Citigroup
47
Citigroup
New York
$1.06M -$1.04M -36,877 -52%
SG Americas Securities
48
SG Americas Securities
New York
$1.06M +$373K +13,214 +63%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$1.03M +$14.1K +499 +2%
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.01M – – –
1
2
3 4 5

ANAB Hedge Fund Activity: Q4 2022 in Review

118 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2022, worth a combined $990M — up 19% from $831M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ANAB positions and 10 closed out — a net gain of 5 holders — while 34 added to existing stakes and 38 trimmed.

The largest buyer was 5AM Venture Management, opening a new position worth an estimated $10.1M. The largest seller was Woodline Partners, cutting an estimated $13.1M.

  • 118 institutional investors held AnaptysBio (ANAB) as of Q4 2022, up from 114 in Q3 2022.
  • Funds reported $990M of AnaptysBio stock for Q4 2022, up 19% quarter-over-quarter.
  • 15 funds opened new AnaptysBio positions in Q4 2022 and 10 closed out, a net change of +5 holders.
  • The largest AnaptysBio buyer in Q4 2022 was 5AM Venture Management, an estimated $10.1M added.
  • The largest AnaptysBio seller in Q4 2022 was Woodline Partners, an estimated $13.1M sold.

Based on aggregated 13F filings for Q4 2022.